{"id": "1337375208991322113", "creation": 1607690071.0, "user_id": "399025508", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "quoted": "1337368688454983681", "text": "Coming up next: Emergency Use Authorization (#EUA) for @BioNTech_Group's #mRNA #vaccine candidate, BNT162b2 against SARS-CoV-2. @US_FDA seems to speed up the process now. European Union's European Medicines Agency (#EMA) to follow at the end of december. Fascinating! #COVID19 https://t.co/13TyWM9vux", "first_save": 1634559108.199414, "hashtags": ["#EUA", "#MRNA", "#VACCINE", "#EMA", "#COVID19"]}